In my practice, I’ve used all the NOAC (novel anticoagulant) therapies available for stroke prevention in my nonvalvular atrial fibrillation patients. I have used dabigatran in my nonvalvular atrial ...

We are past the tipping point with the new oral anticoagulant drugs (NOACs), or direct oral anticoagulants (DOACs). Their dominance over warfarin has arrived. First is ease of use. These days everyone ...

BOSTON, MA — It took about 10 minutes for a single 100- to 300-mg dose of a synthetic anticoagulant antidote to mostly restore clotting time prolonged by 60 mg of edoxaban (Savaysa, Daiichi Sankyo), a ...

DOACs are a newer class of anticoagulants that are more targeted and work faster than traditional options. They also don’t require frequent monitoring and have fewer dietary restrictions. Direct oral ...

Stroke patients treated with intravenous alteplase (Activase) did not have more intracranial hemorrhages if they had recently taken non-vitamin K antagonist oral anticoagulants (NOACs), according to ...

If you’re experiencing severe side effects from the blood thinner warfarin, a doctor may recommend an alternative known as non-vitamin K oral anticoagulants (NOACs). Non-vitamin K oral anticoagulants ...

Anticoagulants are medications that help stop your blood from thickening or “clotting.” Your body does need to be able to clot to help seal wounds inside and outside your body. But unnecessary clots ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — As the number of available novel oral anticoagulants expands, physicians must consider how best to ...

There are currently 4 non-vitamin K antagonist anticoagulants available. These NOAC (novel anticoagulant) therapies include dabigatran, rivaroxaban, apixaban, and edoxaban. First, it’s important to ...